Xeltis Hemodialysis Access Graft (aXess) US Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2032

Conditions
End Stage Renal Disease
Interventions
DEVICE

Xeltis Hemodialysis Access (aXess) graft

The aXess graft is a sterile, restorative biodegradable polymer-based vascular graft, consisting of a tubular structure with a 6mm inner diameter. It is comprised of a highly porous polymer matrix and an embedded electropolished nitinol reinforcement layer (Strain Relief System). The aXess graft is able to support both straight and loop configurations and may be implanted in the upper arm and forearm.

Trial Locations (7)

28210

Surgical Specialists of Charlotte, Charlotte

34239

Sarasota Memorial Hospital, Sarasota

38930

Greenwood Leflore Hospital, Greenwood

77504

Flow Vascular, Surgery Specialty Hospitals of America, Pasadena

85016

AKDHC Medical Research Services, LLC, Phoenix

85718

AKDHC Medical Research Services, LLC, Tuscon

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY

NCT06494631 - Xeltis Hemodialysis Access Graft (aXess) US Study | Biotech Hunter | Biotech Hunter